Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2026
The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy.
Journal: Leukemia
Published: April 22, 2026
Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance.
Journal: Leukemia & lymphoma
Published: April 15, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Journal: American journal of hematology
Published: April 02, 2026
A Phase 1b Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 27, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2026
Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.
Journal: Blood advances
Published: February 02, 2026
Prognostic Ability of Automated RPE Sinuosity for Late AMD Supersedes Qualitative Outer Retinal Band Assessment.
Journal: Investigative ophthalmology & visual science
Published: January 15, 2026
Last Updated: 09/26/2026